You have 9 free searches left this month | for more free features.

City

Bengbu (1)

Changsha (1)

Hangzhou (1)

Modena (1)

Nanchang (1)

Nanjing (1)

Shanghai (1)

Wuhan (1)

Condition

Adenomyosis (1)

Central Precocious Puberty (1)

Prostate Cancer (1)

Overall Status

Completed (1)

Recruiting (1)

Unknown status (1)

Sign in for free

Phase

n/a (1)

phase 4 (1)

Sponsor

Azienda Ospedaliero-Universitaria di Modena (1)

Lee's Pharmaceutical Limited (1)

Takeda (1)

Collaborator

Ministero della Salute, Italy (1)

University of Modena and Reggio Emilia (1)

Intervention

enantone (3)

dienogest 2 mg (milligram) (1)

gnrh agonist (1)

long gnrh agonist or flexible gnrh antagonist protocol. (1)

lutrate (1)

Study Documents

Intervention Type

drug (3)

Funder Type

Industry (2)

Other (1)

Study Type

Interventional (2)

Observational (1)

enantone

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Adenomyosis Trial in Modena (Enantone, Dienogest 2 MG (milligram), long GnRH agonist or flexible GnRH antagonist protocol.)

Recruiting

Adenomyosis

Enantone
+2 more

Modena, Italy

Azienda Ospedaliero-Universitaria di Modena

Jul 6, 2023

Enantone in Central Precocious Puberty Among Chinese

Completed

Has Results

Central Precocious Puberty

Enantone
GnRH agonist

Wuhan, Hubei, China
+5 more

Mar 7, 2022

Prostate Cancer Trial in Bengbu (Lutrate, Enantone)

Unknown status

Prostate Cancer

Lutrate
Enantone

Bengbu, Anhui, China

The First Affiliated Hospital of Bengbu Medical College

Sep 5, 2018